What is StockScout's overall performance for March 2026?

Through March 13, StockScout v2 has closed 34 trades with a total P&L of +$509, a win rate of 52.9% (18 wins, 16 losses). The system trades one-day positions with EOD (end-of-day) exits across approximately 5 simultaneous positions at $10,000 each.

What is the StockScout trading strategy?

StockScout v2 uses a multi-factor ranking system combining VST (composite value/safety/timing score), RS (relative strength), RT (relative timing), and beta. Positions are sized at approximately $10,000 each and held for one day unless macro filters trigger an early exit or hold extension.

What does a VST score mean in StockScout?

VST is StockScout's composite score combining value (fundamental attractiveness), safety (volatility/beta-adjusted risk), and timing (technical entry quality). A VST above 1.2 is considered a strong signal; above 1.0 is acceptable. Stocks below 1.0 are filtered out.

Why did StockScout switch from defense stocks to utilities for March 16?

The system's macro filters respond to real-time conditions. The oil spike (+3.74% WTI) and elevated geopolitical stress (1,181 GDELT events) suppressed BUY signals for most sectors and downgraded lower-safety names. Utilities (NEE, SO) scored highest on safety and timing, replacing defense names (RTX, NOC, GD) which are gone from the watchlist.

What happened to P&L between the last check and March 13 close?

P&L slipped from +$759 to +$509 (-$250) due entirely to Friday's ABBV trade: bought at $225.37, closed at $219.68, -$250 loss (-2.5%). AbbVie's weakness appears to be sector rotation out of healthcare/biotech amid the broader risk-off move.

What stocks is StockScout holding for March 16?

Five HOLDs for the March 16 session: NEE (109 sh @ $91.73, VST 1.23), SO (102 sh @ $97.84, VST 1.22), AAPL (39 sh @ $255.76, VST 1.13), META (15 sh @ $638.18, VST 1.12), ABBV (44 sh @ $225.37, VST 1.02). All are HOLDs, no BUYs — consistent with elevated macro risk filters.

StockScout Trade Book Review: Week of March 9–13, 2026

StockScout Trade Book — Week of Mar 9–13, 2026 | Last updated 16:45 EST

Scorecard

Metric	Value
Total P&L	+$509
Win Rate	52.9% (18W / 16L)
Trades Closed	34
Open Positions	0
P&L Change (vs prior)	-$250 (ABBV Friday loss)

P&L peaked at +$759 mid-week before Friday’s ABBV trade erased the gain differential. Win rate ticked down from 54.5% to 52.9% — still positive expectancy, but tight enough that a two-trade losing streak would push it below 50%.

Full Trade Log

March 13 (Friday)

Ticker	Shares	Entry	Exit	P&L	%
ABBV	44	$225.37	$219.68	-$250	-2.5%

Note: ABBV’s -2.5% move on Friday came during a broad healthcare/biotech selloff. AbbVie’s Humira biosimilar competition headwinds have been a recurring drag — the system’s VST of 1.02 (lowest in the book) was a marginal signal to begin with.

March 12 (Thursday)

Ticker	Shares	Entry	Exit	P&L	%
REGN	13	$759.69	$746.54	-$171	-1.7%
VRTX	20	$487.90	$478.13	-$195	-2.0%
RTX	49	$203.02	$203.04	+$1	+0.0%
JNJ	41	$240.92	$242.39	+$60	+0.6%
XOM	65	$152.03	$153.53	+$98	+1.0%

Biotech (REGN, VRTX) weak — consistent with sector rotation. XOM continues to deliver small positives on oil strength.

March 11 (Wednesday)

Ticker	Shares	Entry	Exit	P&L	%
REGN	12	$770.22	$773.90	+$44	+0.5%
JNJ	41	$241.98	$242.66	+$28	+0.3%
XOM	66	$149.68	$151.42	+$115	+1.2%
NOC	13	$736.64	$735.56	-$14	-0.1%
RTX	48	$206.75	$207.52	+$37	+0.4%

Strong day. XOM +1.2%, RTX +0.4%. Defense names performing well ahead of this week’s geopolitical escalation.

March 10 (Tuesday)

Ticker	Shares	Entry	Exit	P&L	%
NEE	108	$92.01	$91.54	-$51	-0.5%
GOOGL	32	$306.36	$307.04	+$22	+0.2%
PFE	372	$26.81	$27.16	+$130	+1.3%

March 9 (Monday)

Ticker	Shares	Entry	Exit	P&L	%
REGN	13	$759.86	$783.17	+$303	+3.1% ⭐
GD	27	$363.49	$362.11	-$37	-0.4%
JNJ	41	$240.40	$242.52	+$87	+0.9%
XOM	66	$151.21	$150.48	-$48	-0.5%
NOC	13	$756.13	$746.24	-$129	-1.3%

REGN +3.1% was the week’s standout winner — $303 P&L on a single position.

Prior Week (March 4–6)

Ticker	Entry→Exit	P&L	%
REGN Mar 4	$767.05 → $787.50	+$266	+2.7%
RTX Mar 6	$204.01 → $209.76	+$270	+2.8%
NOC Mar 6	$742.27 → $756.13	+$180	+1.9%
CBOE Mar 5	$301.74 → $297.49	-$140	-1.4%
JNJ Mar 5	$242.63 → $239.63	-$123	-1.2%

Pattern Analysis

Best performers by sector:

Biotech (REGN): Top wins (+$303, +$266) but also losses when it reverses
Energy (XOM): Small, consistent gains on most days — low variance
Defense (RTX, NOC): Positive expected value, low variance

Worst performers:

Biotech on down days (REGN, VRTX): Sharp moves in both directions
ABBV: Marginal VST signal, delivered a loss. The system’s 1.02 floor needs review.

Win rate by sector (informal):

XOM: 3W / 2L in the period
REGN: 2W / 2L — high variance, high reward
Defense (RTX/NOC/GD combined): ~4W / 3L

Next Session: Monday March 16

Projections rescored at 8:30 AM ET with fresh data. Current HOLDs:

Ticker	Shares	Entry	~Value	VST	RS	RT	β	P/E
NEE	109	$91.73	~$9,999	1.23	1.25	1.45	0.76	28.2
SO	102	$97.84	~$9,980	1.22	1.35	1.30	0.40	25.4
AAPL	39	$255.76	~$9,975	1.13	1.05	1.00	1.11	31.8
META	15	$638.18	~$9,573	1.12	1.10	1.05	1.26	27.4
ABBV	44	$225.37	~$9,916	1.02	1.25	1.10	0.34	95.3

Key reads on the Monday book:

Utilities dominate (NEE + SO): Highest VST, best RT timing scores, lowest beta. The system is defensively positioned.
AAPL + META: Solid but not exceptional VST. Tech exposure maintained but at lower conviction than utilities.
ABBV at 1.02: Weakest signal in the book. Given Friday’s -2.5% loss, this is the most likely to be rescored lower at Monday’s 8:30 AM update.
No BUYs: Every name is HOLD. The oil spike and elevated geopolitical stress filters are preventing new entry signals.

System data from StockScout v2. Positions are simulated for research purposes. Not financial advice. View live StockScout rankings →